AIFF Firefly Neuroscience, Inc.
Technology$1.69-3.43%ClosedMarket Cap: $26.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.36
P/S
17.20
EV/EBITDA
-2.76
DCF Value
$-0.13
FCF Yield
-28.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.0%
Operating Margin
-539.8%
Net Margin
-565.4%
ROE
-94.7%
ROA
-82.1%
ROIC
-101.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $485.0K | 45.6% | $-2.0M | $-2.0M | $— | — |
| Q4 null | $412.0K | 44.2% | $-2.3M | $-2.5M | $— | — |
| FY null | $1.1M | 56.5% | $-8.6M | $-19.9M | $— | — |
| Q3 null | $388.0K | 37.6% | $-2.7M | $-2.6M | $— | — |
| Q2 null | $299.0K | 91.6% | $-1.6M | $-1.8M | $— | — |
| Q1 null | $43.0K | 100.0% | $-2.1M | $-12.9M | $— | — |
| Q4 null | $53.0K | 100.0% | $-3.4M | $-3.8M | $— | — |
| FY null | $108.0K | 38.0% | $-9.2M | $-10.5M | $— | — |
| Q3 null | $33.0K | -4360.6% | $-4.3M | $-4.3M | $— | — |
| Q2 null | $1.9M | 35.9% | $-382.1K | $-389.7K | $— | — |
| Q1 null | $12.0K | 100.0% | $-1.1M | $-1.1M | $— | — |
| Q4 2023 | $19.0K | 100.0% | $-1.6M | $-1.1M | $-0.14 | — |